NO175846C - Fremgangsmåte for å oppnå et immunogen - Google Patents

Fremgangsmåte for å oppnå et immunogen

Info

Publication number
NO175846C
NO175846C NO890565A NO890565A NO175846C NO 175846 C NO175846 C NO 175846C NO 890565 A NO890565 A NO 890565A NO 890565 A NO890565 A NO 890565A NO 175846 C NO175846 C NO 175846C
Authority
NO
Norway
Prior art keywords
immunogen
retrovirus
hiv
infectious
useful
Prior art date
Application number
NO890565A
Other languages
English (en)
Norwegian (no)
Other versions
NO890565D0 (no
NO175846B (fr
NO890565L (no
Inventor
Jonas Salk
Dennis J Carlo
Original Assignee
Immune Response Corp Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immune Response Corp Inc filed Critical Immune Response Corp Inc
Publication of NO890565D0 publication Critical patent/NO890565D0/no
Publication of NO890565L publication Critical patent/NO890565L/no
Publication of NO175846B publication Critical patent/NO175846B/no
Publication of NO175846C publication Critical patent/NO175846C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3687—Chemical treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Information Retrieval, Db Structures And Fs Structures Therefor (AREA)
NO890565A 1987-06-10 1989-02-09 Fremgangsmåte for å oppnå et immunogen NO175846C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6028087A 1987-06-10 1987-06-10
US20075288A 1988-05-31 1988-05-31
PCT/US1988/001955 WO1988009670A1 (fr) 1987-06-10 1988-06-09 Prevention et traitement de maladies retrovirales

Publications (4)

Publication Number Publication Date
NO890565D0 NO890565D0 (no) 1989-02-09
NO890565L NO890565L (no) 1989-02-09
NO175846B NO175846B (fr) 1994-09-12
NO175846C true NO175846C (no) 1994-12-21

Family

ID=26739775

Family Applications (1)

Application Number Title Priority Date Filing Date
NO890565A NO175846C (no) 1987-06-10 1989-02-09 Fremgangsmåte for å oppnå et immunogen

Country Status (14)

Country Link
EP (3) EP0317622B1 (fr)
JP (1) JPH0720880B2 (fr)
AT (1) ATE132374T1 (fr)
AU (1) AU612383B2 (fr)
CA (1) CA1336407C (fr)
DE (1) DE3854857T2 (fr)
DK (1) DK56389D0 (fr)
FI (1) FI95871C (fr)
IL (1) IL86675A (fr)
NO (1) NO175846C (fr)
OA (1) OA09037A (fr)
RU (1) RU2111010C1 (fr)
UA (1) UA27716C2 (fr)
WO (1) WO1988009670A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0287226A1 (fr) * 1987-03-23 1988-10-19 Hiver Limited Vaccin
US5256767A (en) * 1987-06-10 1993-10-26 The Immune Response Corporation Retroviral antigens
US5227159A (en) * 1989-01-31 1993-07-13 Miller Richard A Anti-idiotype antibodies reactive with shared idiotopes expressed by B cell lymphomas and autoantibodies
WO1990015133A1 (fr) * 1989-05-30 1990-12-13 Nippon Zeon Co., Ltd. Procede de production de structures de noyau de retrovirus et particules ainsi produites
FR2661834B1 (fr) * 1990-05-09 1995-01-27 Merieux Inst Procede de fabrication d'immunogenes de retrovirus et de vaccins contre les infections retrovirales, notamment hiv, et immunogenes et vaccins obtenus.
AU4685293A (en) * 1992-07-20 1994-02-14 Immune Response Corporation, The Prophylactic and therapeutic control of retroviral infections
ATE189697T1 (de) * 1994-03-22 2000-02-15 Immune Response Corp Inc Die hocheffiziente herstellung und isolierung von viruspartikeln
IT1271593B (it) * 1994-11-30 1997-06-04 Sanitaria Scaligera Spa Procedimento ed apparecchiatura per l'immunoadsorbimento specifico di virus hiv, di antigene gp120 e complesso cd4-gp120.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4716102A (en) * 1984-08-15 1987-12-29 Regents Of The University Of California Purified AIDS-associated virus ARV-2
DK507185A (da) * 1984-11-05 1986-05-06 Du Pont Fremgangsmaade til inaktivering af human tumor leukaemi virus iii
US4725669A (en) * 1984-11-09 1988-02-16 President And Fellows Of Harvard College Assay for detecting infection by human T-cell lymphotropic virus-III
AU600658B2 (en) * 1984-12-24 1990-08-23 Genentech Inc. Molecularly cloned acquired immunodeficiency syndrome polypeptides and their methods of use
DE3650011T2 (de) * 1985-04-08 1994-11-17 Genetic Systems Corp EXPRESSION UND DIAGNOSE MIT gag-KODIERTEN PEPTIDEN, DIE MIT ANTIKÖRPERN GEGEN LAV IMMUNOLOGISCH REAKTIV SIND.
NZ215867A (en) * 1985-04-19 1989-10-27 Hoffmann La Roche Aids envelope protein, dna vectors and method of production
WO1987002892A1 (fr) * 1985-11-14 1987-05-21 President And Fellows Of Harvard College Virus t-lymphotrophique
EP0250128A3 (fr) * 1986-06-18 1988-06-08 American Registry of Pathology Virus isolé de patients atteints du SIDA
CA1341277C (fr) * 1987-03-16 2001-07-31 Roland Keith Mcgready Anticorps anti-paratopique et son procede de fabrication

Also Published As

Publication number Publication date
FI890603A0 (fi) 1989-02-08
WO1988009670A1 (fr) 1988-12-15
NO890565D0 (no) 1989-02-09
OA09037A (en) 1991-03-31
EP0685236A1 (fr) 1995-12-06
EP0317622B1 (fr) 1996-01-03
NO175846B (fr) 1994-09-12
EP0602761A1 (fr) 1994-06-22
DE3854857D1 (de) 1996-02-15
UA27716C2 (uk) 2000-10-16
CA1336407C (fr) 1995-07-25
FI95871C (fi) 1996-04-10
EP0317622A1 (fr) 1989-05-31
RU2111010C1 (ru) 1998-05-20
DK56389A (da) 1989-02-08
IL86675A (en) 1993-04-04
AU1962688A (en) 1989-01-04
FI95871B (fi) 1995-12-29
JPH0720880B2 (ja) 1995-03-08
ATE132374T1 (de) 1996-01-15
DE3854857T2 (de) 1996-08-22
FI890603A (fi) 1989-02-08
AU612383B2 (en) 1991-07-11
DK56389D0 (da) 1989-02-08
JPH02500440A (ja) 1990-02-15
NO890565L (no) 1989-02-09
EP0317622A4 (fr) 1990-05-14

Similar Documents

Publication Publication Date Title
MY103182A (en) Vaccines against acquired immune deficiency syndrome.
DE68927348D1 (de) Künstlicher impfstoff gegen aids-virus
DK0778888T3 (da) Antigen-mærket ikke-infektiös retroviruslignende partikel
RU94042386A (ru) Вакцина против гепатита, содержащая 3-0-дезацилированный монофосфорил-липида, применение антигена гепатита для получения препарата для лечения гепатита, способ лечения гепатита
DK1276896T3 (da) Epitop-synkronisering i antigen-præsenterende celler
EP0330359A3 (fr) Composition utile pour le diagnostic et le traitement de l'infection par le HIV-I
ATE119042T1 (de) Verwendung eines viralen glykoprotein-impstoffes für intranasale immunisierung gegen eine virusinfektion.
NO175846C (no) Fremgangsmåte for å oppnå et immunogen
ATE188484T1 (de) Immunologisch mit hla homologe hiv protein epitope
IE881282L (en) Monoclonal antibodies to specific antigenic regions of the¹human immunodeficiency virus and methods for use.
FR2385401A1 (fr) Vaccin a virus respiratoire syncytial
ATE284709T1 (de) Virale chimären aus caev und hiv-1 genetischen elementen
ITRM950209A1 (it) Vaccino per la profilassiimmunitaria dell'infezione da virus della immunodeficienza felina del gatto domestico.
EP0320034A3 (fr) Peptides synthétiques immunologiquement actifs utilisables pour préparer un vaccin contre le paludisme
ATE207364T1 (de) Caprin arthritis-enzephalitis virus enthaltende vakzine und verwendung zur immunschutz gegen hiv- 1 infektion
EP0250128A3 (fr) Virus isolé de patients atteints du SIDA
ATE111485T1 (de) Peptidbehandlung von hartnäckigen infektionskrankheiten.
EP0309898A3 (fr) Méthode pour l'induction d'une réponse de cellule T cytotoxique
SU1739559A1 (ru) Штамм вируса aphtae epizooticae типа o, используемый для изготовления диагностических сывороток и антигенных препаратов
PT90800A (pt) Processo para a preparacao de antigenios precursores das glicoproteinas de involucro de um retrovirus humano hiv-2 e de antigenios que apresentem uma analogia imonulogiga com estes ultimos e sua aplicacao ao diagnostico
ZA88310B (en) Peptides capable of being recognized by antibodies induced against human immunodeficiency retrovirus(hiv-virus),their applications for diagnosis of infections caused by some of these viruses and,in case,to vaccination against aids